{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:35:33Z","timestamp":1793957733591,"version":"4.8.0"},"reference-count":51,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T00:00:00Z","timestamp":1108512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p>Nifedipine (Adalat) is marketed as an anti\u2010hypertensive agent. Nifedipine inhibits voltage\u2010dependent L\u2010type calcium channels, which leads to vascular (and other) smooth muscle relaxation and negative inotropic and chronotropic effects on the heart. Vasodilation, followed by a baroreceptor\u2010mediated increase in sympathetic tone then results in indirect cardiostimulation. Nifedipine was introduced as a tocolytic agent at a time when \u03b2\u2010agonists and magnesium sulphate dominated the arena for the prevention of preterm birth. The oral administration route, the availability of immediate and slow\u2010release preparations, the low incidence of (mild) side effects, and its limited costs explain the attraction to this medication from the obstetric field and its rapid and widespread distribution. Currently, over 40 studies have been published on nifedipine's tocolytic effectiveness, including seven meta\u2010analyses. The quality of the studies suffers particularly from performance bias because the majority of them failed to ensure adequate blinding to treatment both for providers and patients. Concerns about other methodological flaws include measurements, outcome assessment and attrition bias. In particular, the safety aspects of nifedipine for tocolysis have been underassessed. Conclusions from the meta\u2010analyses, favouring the use of nifedipine as a tocolytic agent, are not supported by close examination of the data. The tocolytic effectiveness and \u2018safety\u2019 of nifedipine has been studied primarily in normal pregnancies. Based on its pharmacological properties, one should be cautious to administer nifedipine when the maternal cardiovascular condition is compromised, such as with intrauterine infection, twin pregnancy, maternal hypertension, cardiac disease, <jats:italic>etc.<\/jats:italic> Life\u2010threatening pulmonary oedema and\/or cardiac failure are definite risks and have been reported. Under such circumstances, the baroreceptor\u2010mediated increase in sympathetic tone may not balance the cardiac\u2010depressant activity of nifedipine.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2005.00591.x","type":"journal-article","created":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T22:50:00Z","timestamp":1108594200000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Nifedipine trials: effectiveness and safety aspects"],"prefix":"10.1111","volume":"112","author":[{"given":"Herman P.","family":"van Geijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris E.","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke C.","family":"Bolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,2,16]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00329-4"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.820101.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00218.x"},{"key":"e_1_2_8_5_2","first-page":"694","volume-title":"Effective Care in Pregnancy and Childbirth","author":"Keirse MJNC","year":"1989"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(03)00145-0"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)90331-9"},{"key":"e_1_2_8_8_2","first-page":"131","volume-title":"A Guide to Effective Care in Pregnancy and Childbirth","author":"Enkin M","year":"1989"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530030-00002"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00548-0"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13222.x"},{"key":"e_1_2_8_12_2","first-page":"536","article-title":"Relaxing effects of nifedipine on the pregnant uterus in vitro and vivo","volume":"52","author":"Ulmsten U","year":"1978","journal-title":"Obstet Gynecol"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1979.tb10590.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90909-5"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1992.tb04505.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1986.tb08011.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90403-1"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)90679-6"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)91624-X"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(97)00255-8"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199404000-00024"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.1999.780908.x"},{"key":"e_1_2_8_23_2","first-page":"259","article-title":"Meta\u2010analysis of nifedipine versus beta\u2010sympathicomimetic agents for tocolysis during preterm labour","volume":"20","author":"Ray JG","year":"1998","journal-title":"J Soc Obstet Gynaecol Canada"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(00)01212-6"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002255"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8666.2003.00074.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1471-0528.2003.03071.x","article-title":"Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta\u2010analysis with an indirect comparison of randomized controlled trials","volume":"110","author":"Coomarasamy A","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"e_1_2_8_28_2","first-page":"CD004071","article-title":"Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour","author":"Gaunekar NN","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(97)00255-8"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70308-X"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2004.041"},{"key":"e_1_2_8_32_2","first-page":"478","article-title":"A randomized study of the treatment of threatened premature labor. Nifedipine versus ritodrine","volume":"19","author":"Janky E","year":"1990","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(01)00547-1"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999417"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1993.tb15171.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(97)02701-2"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(98)00053-8"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00182-8"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00596-7"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610410001660643"},{"key":"e_1_2_8_41_2","unstructured":"LamontRF KhanKS BeattieRB et al.The quality of trials of tocolytic effectiveness in spontaneous preterm labour: a systematic review of nifedipine trials. Unpublished data."},{"key":"e_1_2_8_42_2","unstructured":"Bayer Health Care on Adalat\u00aeCC (nifedipine) extended release tablets for oral use (08753752) 2004:1\u20137."},{"key":"e_1_2_8_43_2","unstructured":"Rx list monograph on the side effects of immediate release capsules and extended release tablets of nifedipine 2003:1\u20137."},{"key":"e_1_2_8_44_2","first-page":"199","article-title":"Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios","volume":"75","author":"Mari G","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_8_45_2","first-page":"192","article-title":"The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension","volume":"79","author":"Puzey MS","year":"1991","journal-title":"S Afr Med J"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1988.tb06818.x"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999503"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400219"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00092.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.2143\/AC.59.3.2005191"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.05.004"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051613"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2005.00591.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2005.00591.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:53:12Z","timestamp":1694656392000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2005.00591.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,16]]},"references-count":51,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1471-0528.2005.00591.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2005.00591.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,16]]},"assertion":[{"value":"2005-02-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}